Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $197.58 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $76.88 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $38.30 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $32.86 | 2 | $0 (2023) |
| Boston Scientific Corporation | $19.65 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $16.81 | 1 | $0 (2023) |
| AbbVie Inc. | $13.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $104.80 | 6 | Merck Sharp & Dohme LLC ($38.30) |
| 2022 | $15.90 | 1 | AstraZeneca Pharmaceuticals LP ($15.90) |
| 2017 | $76.88 | 1 | Janssen Pharmaceuticals, Inc ($76.88) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/06/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: WATCHMAN_IC | ||||||
| 04/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Cardiovascular | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/09/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/30/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $76.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 410 | 715 | $180,521 | $49,815 |
| 2022 | 8 | 252 | 451 | $67,422 | $27,517 |
| 2021 | 9 | 283 | 492 | $70,018 | $30,045 |
| 2020 | 8 | 317 | 559 | $86,080 | $37,972 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 161 | 429 | $87,312 | $25,721 | 29.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 60 | $33,608 | $7,816 | 23.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 63 | 67 | $20,079 | $5,668 | 28.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 61 | 61 | $13,330 | $3,720 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 35 | $9,970 | $3,163 | 31.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $9,936 | $2,232 | 22.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 40 | $6,286 | $1,495 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 265 | $37,100 | $14,559 | 39.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $7,455 | $3,252 | 43.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 33 | 33 | $6,237 | $2,651 | 42.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 34 | $6,392 | $2,623 | 41.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 35 | 35 | $4,550 | $1,902 | 41.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 36 | $2,628 | $1,048 | 39.9% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 13 | 15 | $1,500 | $821.93 | 54.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,560 | $662.36 | 42.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 114 | 269 | $37,660 | $15,461 | 41.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 61 | 65 | $8,450 | $3,611 | 42.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 31 | $5,828 | $2,686 | 46.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $4,260 | $1,919 | 45.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 19 | 19 | $3,591 | $1,660 | 46.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 49 | $3,577 | $1,473 | 41.2% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 17 | 23 | $2,300 | $1,307 | 56.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $2,662 | $1,197 | 45.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 13 | $1,690 | $732.03 | 43.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 106 | 274 | $38,360 | $16,177 | 42.2% |
About Dr. Timothy Carpenter, M.D
Dr. Timothy Carpenter, M.D is a Hospitalist healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1437419256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Carpenter, M.D has received a total of $197.58 in payments from pharmaceutical and medical device companies, with $104.80 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($197.58).
As a Medicare-enrolled provider, Carpenter has provided services to 1,262 Medicare beneficiaries, totaling 2,217 services with total Medicare billing of $145,349. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Family Medicine
- Location Latrobe, PA
- Active Since 05/26/2012
- Last Updated 01/20/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1437419256
Products in Payments
- INVOKANA (Drug) $76.88
- DIFICID (Drug) $38.30
- WATCHMAN Access System (Device) $19.65
- FARXIGA (Drug) $16.96
- ELIQUIS (Drug) $16.81
- BRILINTA (Drug) $15.90
- AVYCAZ (Drug) $13.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.